jueves, 28 de febrero de 2013

Depressed Patients May Gain From Self-Help Books, Websites: MedlinePlus

Depressed Patients May Gain From Self-Help Books, Websites: MedlinePlus

MedlinePlus Logo

Depressed Patients May Gain From Self-Help Books, Websites

These low-intensity interventions deemed good first steps in treatment
(*this news item will not be available after 05/28/2013)
By Robert Preidt
Wednesday, February 27, 2013 HealthDay Logo
HealthDay news image
Related MedlinePlus Page
TUESDAY, Feb. 26 (HealthDay News) -- Self-help books and websites can benefit people with severe depression and should be included as part of the first line of treatment, a new study suggests.
For the report, the researchers reviewed several studies that included a total of nearly 2,500 adult patients with different degrees of depression who received treatment outside of a hospital.
Patients with more severe depression derived at least as much benefit from low-intensity interventions -- such as self-help books and interactive websites -- as those with less severe depression, according to the report published online Feb. 26 in the BMJ.
These types of low-intensity interventions are meant to help patients manage their depressive symptoms, often with limited support from a health professional, the researchers explained in a journal news release.
The findings indicate that low-intensity interventions should be included as part of the first step of depression treatment and that patients should be encouraged to use them, concluded Peter Bower, of the University of Manchester in England, and colleagues.
The authors also suggested that future research should examine whether low-intensity treatments are cost-effective compared to longer and more expensive psychological therapies, and determine how low-intensity intervention in the first stage of treatment might affect future treatment.
SOURCE: BMJ, news release, Feb. 26, 2013
HealthDay

More Health News on:
Depression

Do bariatric surgery restrictions improve outcomes?: MedlinePlus

Do bariatric surgery restrictions improve outcomes?: MedlinePlus


MedlinePlus Logo

Do bariatric surgery restrictions improve outcomes?

(*this news item will not be available after 05/27/2013)
Tuesday, February 26, 2013 Reuters Health Information Logo
Registered Nurse Amanda Tyacke (L) injects saline solution through the abdomen of Jazmine Raygoza, 17 (R) into an under-skin port which will fill Raygoza's Lap-Band at Rose Medical Center in Denver August 3, 2011 about 6 weeks after Jazmine's surgery. After trying multiple diets and exercise Raygoza decided on the surgery with the encouragement of her mother Veronica who recently had gastric bypass. At the six week mark Jazmine had lost 21 pounds. REUTERS/Rick Wilking
Related MedlinePlus Page
By Genevra Pittman
NEW YORK (Reuters Health) - A Medicare policy limiting where people can undergo weight-loss surgery to so-called "centers of excellence" was not responsible for reducing complications from the procedures, according to a new study.
In 2006, the Centers for Medicare & Medicaid Services (CMS) said it would only pay for bariatric surgery done at hospitals that had certain equipment and medical teams in place and were certified by the American College of Surgeons or the American Society for Metabolic and Bariatric Surgery (ASMBS).
"About a decade ago, there were very real concerns that there were safety problems with bariatric surgery," said Dr. Justin Dimick, who led the new study at the University of Michigan in Ann Arbor.
At some hospitals, he said, as many as nine percent of patients died during or after surgery.
But that started changing before CMS stepped in with new restrictions, according to Dimick, in part due to less-invasive surgical techniques and better surgeon training.
He and his colleagues used billing codes to track bariatric surgery complications, such as leaks and bleeding, during about 300,000 procedures done between 2004 and 2009 both at centers of excellence and at other hospitals.
They found the proportion of patients on Medicare who had any procedure-related complication dropped from 12 percent before the policy change to eight percent afterward, according to findings published Tuesday in the Journal of the American Medical Association.
In non-Medicare patients - who had no restrictions on where they received surgery - complication rates also dropped, from between six and seven percent to below five percent.
More complications are to be expected among Medicare patients, the researchers said, due to their age.
"Bariatric surgery got a lot safer over this time period… but it happened in both Medicare and non-Medicare patients," Dimick told Reuters Health.
"The policy was implemented in 2006, and outcomes were getting better well before that," he added. "The evidence shows that the policy itself had no benefit."
Dr. Jaime Ponce, president of ASMBS, disagreed with that assessment and said the new study was limited by its use of billing data instead of more detailed patient records.
"It's very difficult to say that accreditation has not helped hospitals or bariatric surgery programs," said Ponce, who was not involved in the new research.
Previous studies showed the CMS policy was linked to a reduction in procedure costs and in deaths after surgery, he noted.
Ponce said the policy may have encouraged both hospitals that did and didn't end up being considered centers of excellence to improve their patient care.
"What (the study) showed is that all of the hospitals improved over time," he told Reuters Health.
According to ASMBS, about 200,000 people have weight loss surgery every year. Surgery is typically recommended for people with a body mass index - a measure of weight in relation to height - of at least 40, or at least 35 if they also have co-occurring health problems such as diabetes or severe sleep apnea.
Dimick and his colleagues are pushing for a move away from the current certification system, toward one that provides more feedback for all hospitals that perform bariatric surgery. Ponce, however, said the Medicare policy is helping patients and should remain in place.
A representative from CMS said the agency is examining its bariatric surgery coverage, including the certification requirement, "and can't comment on it until we issue a final decision." That report is expected later this year.
One drawback of the current policy, Dimick said, is that some people on Medicare can't be treated at nearby hospitals that perform bariatric surgery but aren't certified.
"The harms here are that Medicare patients who needed surgery might not have been able to have it, because it required travel somewhere else," he said.
SOURCE: http://bit.ly/MvXYT6 Journal of the American Medical Association, online February 26, 2013.
Reuters Health

More Health News on:
Weight Loss Surgery

Advanced breast cancer inching up in young women: MedlinePlus

Advanced breast cancer inching up in young women: MedlinePlus

 
MedlinePlus Logo

Advanced breast cancer inching up in young women

(*this news item will not be available after 05/27/2013)
Tuesday, February 26, 2013 Reuters Health Information Logo
Related MedlinePlus Pages
By Genevra Pittman
NEW YORK (Reuters Health) - More young women are being diagnosed with advanced, metastatic breast cancer than were three decades ago, a new study suggests - although the overall rate of cancers in that group is still small.
One in 173 women will develop breast cancer before she turns 40, researchers said, and the prognosis tends to be worse for younger patients.
In the new study, a team led by Dr. Rebecca Johnson at Seattle Children's Hospital and the University of Washington found the rate of metastatic breast cancer, in particular, rose about two percent each year between 1976 and 2009 among younger women.
"We think that the likelihood is that since this change has been so marked over just a couple of decades, that it's something external, a modifiable lifestyle-related risk factor or perhaps an environmental toxic exposure, but we don't know what," Johnson said.
One possibility is that overeating and lack of exercise are driving up early-life metastatic breast cancer rates, Johnson added. Or, the use of hormonal birth control could play a role, she said. But Johnson also pushed for more research into the potential effects of hormones in meat or plastic in bottles, for example.
Johnson and her colleagues analyzed data from cancer registries run by the National Cancer Institute.
As expected, they found that the number of early breast cancer diagnoses increased among middle-aged and older women during the study period, likely due to widespread screening.
The only other change in cancer incidence was among the youngest women, between ages 25 and 39. In that group, the number of women diagnosed with metastatic breast cancer - which has spread to the bones, brain or lungs - rose from one in 65,000 in 1976 to one in 34,000 in 2009.
More of the increase appeared to be in cancers that are sensitive to estrogen, which is "comparatively fortunate," the authors note, because those cancers are somewhat more responsive to treatment and have longer average survival rates in general.
Still, metastatic cancer is the most dangerous kind, with less than one-third of women surviving at least five years after diagnosis, Johnson's team wrote Tuesday in the Journal of the American Medical Association.
Surgeon Dr. Julie Margenthaler, who has studied breast cancer in young women at the Washington University School of Medicine in St. Louis, said the new study was limited by a lack of data on women's family history, including which ones were carriers of BRCA gene mutations.
Women with those mutations are known to be at high risk of developing breast and ovarian cancer at a young age.
"It is intriguing data, but I think that it's going to have to be validated in some other datasets," said Margenthaler, who was not involved in the new research.
Because the overall rate of cancer in young women is still low, Johnson said the findings shouldn't cause alarm - but should prompt further research.
"We're certainly not advocating any changes in screening mammography practices. This is an increase, but it's small on a population level," she told Reuters Health. "There's no reason that because you're 35 and see this report, you need to go out and get a mammogram right away."
Margenthaler agreed.
"A small statistical change does not translate into changing practice patterns," she told Reuters Health. "It doesn't mean we can base major treatment or decision-making changes on this alone. Overall, it's a pretty small absolute change."
The government-backed U.S. Preventive Services Task Force recommends that women between age 50 and 74 get a mammogram every other year, with the option to start earlier based on a woman's own values.
Johnson said women should still be aware that cancer can happen at an early age, even if screening isn't recommended.
"Women need to notice changes in their bodies - breast lumps, feeling bad, and promptly seek medical attention for those," she said. "There's a tremendous survival improvement associated with diagnosis before the cancer spreads."
SOURCE: http://bit.ly/MvXYT6 Journal of the American Medical Association, online February 26, 2013.
Reuters Health

More Health News on:
Breast Cancer
Health Statistics

Niacin-Statin Combo May Cause Side Effects for Heart Patients: MedlinePlus

Niacin-Statin Combo May Cause Side Effects for Heart Patients: MedlinePlus

 
MedlinePlus Logo

Niacin-Statin Combo May Cause Side Effects for Heart Patients

Study found that about one-quarter of participants dropped the vitamin due to adverse effects
(*this news item will not be available after 05/28/2013)
By Robert Preidt
Wednesday, February 27, 2013 HealthDay Logo
HealthDay news image
Related MedlinePlus Pages
TUESDAY, Feb. 26 (HealthDay News) -- Combining the vitamin niacin with a cholesterol-lowering statin drug appears to raise side effects in heart patients, a new study indicates.
Muscle, skin and gastrointestinal problems were among the side effects that caused one-quarter of patients to stop treatment in a study looking at whether the use of niacin in combination with a statin might reduce heart disease risk.
Niacin has long been used to boost levels of "good" HDL cholesterol and decrease levels of "bad" LDL cholesterol and triglycerides (fats) in the blood in people at risk for heart disease and stroke. However, niacin also causes a number of side effects, including flushing of the skin. A drug called laropiprant can reduce the incidence of flushing in people taking niacin.
This new study included nearly 26,000 patients with narrowing of the arteries. They received either 2 grams of extended-release niacin plus 40 milligrams of laropiprant or matching placebos. All of the patients also took the statin drug Zocor (simvastatin).
The patients from China, the United Kingdom and Scandinavia were followed for an average of almost four years. By the end of the study, 25 percent of patients taking niacin plus laropiprant had stopped their treatment, compared with 17 percent of the patients taking a placebo, according to the findings published online Feb. 26 in the European Heart Journal.
"The main reason for patients stopping the treatment was because of adverse side effects, such as itching, rashes, flushing, indigestion, diarrhea, diabetes and muscle problems," Jane Armitage, professor of clinical trials and epidemiology at the University of Oxford, said in a journal news release. "We found that patients allocated to the experimental treatment were four times more likely to stop for skin-related reasons, and twice as likely to stop because of gastrointestinal problems or diabetes-related problems."
Patients taking niacin and laropiprant had a more than a fourfold increased risk of muscle pain or weakness compared to the placebo group, the team noted.
Still, the final verdict on whether niacin is worth taking is yet to come, the researchers said.
"Although 25 percent of patients stopped the treatment early, 75 percent continued on it for approximately four years," Dr. Richard Haynes, clinical coordinator at Oxford's Clinical Trial Service Unit and Epidemiological Studies Unit, said in the news release. "Currently, we are analyzing the final data on the cardiovascular outcomes from the trial, and once we have these we will know whether or not the benefits of the treatment outweigh the [risks]."
One U.S. expert was less than impressed by niacin's performance.
The trial "confirms that, for the present moment, there may be little additional benefit with the use of niacin when patients are well treated with the lipid-lowering statin drugs," said Dr. Kevin Marzo, chief of cardiology at Winthrop-University Hospital in Mineola, N.Y.
He said that the results of the new trial, along with those from a prior large study, "now may put the final nail in the coffin on niacin-based strategies to raise HDL and lower cardiovascular events."
Other tried-and-true approaches may work best, Marzo added. "In addition to statins, our focus should be on continued lifestyle changes such as a Mediterranean diet, complemented with daily exercise," he said.
The full results on the study are expected to be presented at the annual meeting of the American College of Cardiology in March, and will be published in another paper.
SOURCES: Kevin Marzo, MD, chief of cardiology, Winthrop-University Hospital, Mineola, NY; European Heart Journal, news release, Feb. 26, 2013
HealthDay

More Health News on:
Drug Reactions
Heart Diseases

Most New Mothers Skip Sex for at Least 6 Weeks After Childbirth: MedlinePlus

Most New Mothers Skip Sex for at Least 6 Weeks After Childbirth: MedlinePlus

 

MedlinePlus Logo

Most New Mothers Skip Sex for at Least 6 Weeks After Childbirth

Australian study found type of delivery, age of woman made a difference
(*this news item will not be available after 05/28/2013)
By Robert Preidt
Wednesday, February 27, 2013 HealthDay Logo
HealthDay news image
Related MedlinePlus Pages
TUESDAY, Feb. 26 (HealthDay News) -- Most first-time mothers wait more than six weeks after childbirth before having sex again, a new study finds.
Australian researchers examined data from more than 1,500 women and found that 41 percent of these new mothers attempted vaginal sex by six weeks after giving birth, 65 percent by eight weeks, 78 percent by 12 weeks and 94 percent by six months.
Although most of the women waited longer before having vaginal sex, 53 percent of them resumed some form of sexual activity within six weeks, according to the study, which was published Feb. 27 in BJOG: An International Journal of Obstetrics and Gynaecology.
Women aged 30 to 34 were much less likely than those aged 18 to 24 to resume vaginal sex by six weeks after giving birth: 40 percent versus 63 percent.
Women who had a cesarean section, a birth assisted with forceps or an episiotomy or sutured tear also were less likely to have resumed vaginal sex by six weeks after birth. The rates were 45 percent for those who had a C-section, 32 percent for those who had a forceps-assisted birth, 32 percent for those who had an episiotomy and 35 percent for those who had a sutured tear. In comparison, 60 percent of women who had spontaneous vaginal birth with intact perineum resumed sex within six weeks.
Only about 10 percent of first-time mothers will have a vaginal birth and an intact perineum, according to the study, so it's reasonable for most women and their partners to expect a delay in resuming vaginal sex, the researchers said.
"The most important finding from the study is the wide time interval over which couples resume sex after childbirth," study lead author Stephanie Brown, an associate professor at the Murdoch Children's Research Institute in Victoria, said in a journal news release. "Most couples do not resume sex until after six to eight weeks postpartum, and many delay much longer than this."
"This is useful information for couples to know before their baby is born, and may help reduce feelings of anxiety and guilt about not resuming sexual activity sooner," she said.
John Thorp, the journal's deputy editor-in-chief, said in the news release: "It is very common for women and their partners to want information about when sexual activity may be safely and comfortably resumed, and what to expect in relation to the impact of childbirth on their relationship."
"It is important to remember that these decisions are down to the individual couple and when it feels right for them," he said.
SOURCE: BJOG: An International Journal of Obstetrics and Gynaecology, news release, Feb. 26, 2013
HealthDay

More Health News on:
Childbirth
Sexual Health

H1N1 Swine Flu Vaccine Tied to Sleep Disorder in British Children: MedlinePlus

H1N1 Swine Flu Vaccine Tied to Sleep Disorder in British Children: MedlinePlus
 
MedlinePlus Logo

H1N1 Swine Flu Vaccine Tied to Sleep Disorder in British Children

Pandemrix also found to raise narcolepsy risk in previous European studies
(*this news item will not be available after 05/28/2013)
By Robert Preidt
Wednesday, February 27, 2013 HealthDay Logo
HealthDay news image TUESDAY, Feb. 26 (HealthDay News) -- A British study finds that children and teens who were vaccinated during the 2009 swine flu outbreak are at increased risk for narcolepsy, a disorder that causes people to fall asleep during the day.
The particular flu vaccine involved has never been licensed for use in the United States, according a statement on the U.S. Centers for Disease Control and Prevention website.
Researchers looked at data from children and teens aged 4 to 18 who were treated at sleep centers and neurology centers in England, and concluded that receiving the Pandemrix vaccine was associated with a 14- to 16-fold increased risk of developing narcolepsy.
They also determined that one in 52,000 to 57,500 doses of the vaccine are associated with narcolepsy, according to the study published online Feb. 26 in the journal BMJ.
The findings are consistent with previous studies in other countries, said Elizabeth Miller, of the Health Protection Agency in the United Kingdom, and colleagues. For example, a 2012 study from Finland found a 13-fold increased risk of narcolepsy in children and teens aged 4 to 19 who received the Pandemrix vaccine.
The authors of the new study wrote that the findings do indicate a "causal" link between the vaccine and the sleep disorder. They added, however, that the risk may still be overestimated and added that long-term monitoring of children and teens who received the vaccine is needed to determine the exact level of risk.
The 2009 H1N1 swine flu pandemic sickened millions of people and caused more than 18,000 deaths in more than 200 countries. In England, the Pandemrix vaccine was introduced in October 2009. By March 2010, 24 percent of healthy children younger than age 5 and 37 percent of those aged 2 to 15 in an at-risk group had been vaccinated.
SOURCE: BMJ, news release, Feb. 26, 2013
HealthDay

Breast Cancer in the U.S.: MedlinePlus Health News Video

VIDEO ►
Breast Cancer in the U.S.: MedlinePlus Health News Video


A service of the U.S. National Library of Medicine
From the National Institutes of HealthNational Institutes of Health